Brad Prybis, MD
Orthopaedic Surgery of the Spine · Stockbridge, GANPI 1245296391
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (48.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Globus Medical at 26.7% of the total. Reporting peaked in 2019 at $149,329 and has fallen 59.9% since, to $59,865 in 2025. Among orthopaedic surgery of the spine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 828 payments — averaging $795.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$176K
- Royal Biologics, Inc.$169K
- Stryker$123K
- 4web, Inc.$117K
- Medical Investment Advisors LLC$27K
- Spineart SA$24K
- plus $23K from 27 others
Across 15 payments — averaging $10,370 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smart-surgical Inc. Dba Burst Biologics$78K
- Royal Biologics, Inc.$77K
- Globus Medical$1K
Across 7 payments — averaging $18,842 each. An ownership or investment interest held by the physician or an immediate family member.
- 4web, Inc.$132K
What the payments were for
- Royalty or licence$319,13048%
- Consulting fees$231,38835%
- Speaking & faculty fees$17,8313%
- Travel & lodging$59,7169%
- Food & beverage$30,6185%
- Entertainment$1040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 91 | $176,199 |
| Royal Biologics, Inc. | 58 | $168,910 |
| Stryker | 175 | $123,162 |
| 4web, Inc. | 409 | $116,580 |
| Medical Investment Advisors LLC | 13 | $26,881 |
| Spineart SA | 12 | $23,557 |
| Intelivation Technologies, LLC | 5 | $11,125 |
| Spineart USA Inc | 12 | $6,656 |
| Mirus, LLC | 1 | $2,655 |
| Orthofix Medical, Inc. | 6 | $928 |
| Spinal Elements, Inc. | 11 | $406 |
| Ossdsign USA Incorporated | 3 | $352 |
| Medtronic | 1 | $163 |
| Vertex | 2 | $153 |
| Alafair Biosciences, Inc. | 1 | $127 |
| Cerapedics Inc. | 1 | $119 |
| Spine Wave, Inc. | 1 | $112 |
| Amgen | 6 | $94 |
| DJO, LLC | 2 | $92 |
| Si-bone, Inc. | 3 | $83 |
| Smith+Nephew | 1 | $79 |
| Ulrich Medical USA, Inc. | 1 | $61 |
| Xtant Medical Inc | 1 | $51 |
| Curonix LLC | 2 | $46 |
| Nexxt Spine LLC | 1 | $38 |
| Baxter Healthcare | 2 | $37 |
| Bioventus LLC | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $23 |
| Providence Medical Technology, Inc. | 1 | $20 |
| Pacira Therapeutics, Inc. | 1 | $15 |
| Medacta USA, Inc. | 1 | $15 |
| Heraeus Medical, LLC. | 1 | $13 |
| Polarityte, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTEND$118,476
- SPINE TRUSS SYSTEM$105,408
- TRITANIUM$51,677
- ES2 SPINAL SYSTEM$36,888
- ELSA$20,302
- PERLA C$20,294
- AIRO$20,250
- EVEREST SPINAL SYSTEM$19,500
- ALTERA$18,300
- CASCADIA$16,652
- RAVINE LATERAL ACCESS SYSTEM$15,165
- ES2$14,821
- CASCADIA INTERBODY SYSTEM$12,969
- NIAGARA LATERAL ACCESS SYSTEM$9,100
- MONTEREY AL$9,100
- ARIA$9,000
- EVEREST XT$9,000
- NAV - NAV3 NAVIGATION PLATFORM$8,634
- MANTIS$8,500
- SERRATO$7,391
How this compares
$658,786 in reported general payments places this provider in the 90th percentile of 57 orthopaedic surgery of the spine providers in Georgia.
See all orthopaedic surgery of the spine providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 297 | $2,186 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 160 | $1,787 |
| Methocarbamol | 96 | $950 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $659 |
| Diclofenac Sodium | 39 | $612 |
| Tizanidine Hcl | 60 | $538 |
| Promethazine Hcl | 75 | $417 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $367 |
| Pregabalin | 33 | $319 |
| Cyclobenzaprine Hcl | 36 | $289 |
| Tramadol Hcl | 70 | $264 |
| Ibuprofen | 22 | $219 |
| Nabumetone | 29 | $131 |
| Methylprednisolone | 19 | $58 |
| Meloxicam | 15 | $54 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Stockbridge
- Henaku YirenkyiStockbridge$5K
- John HellerAtlanta$4.2M
- Scott BodenAtlanta$1.5M
- Justin BundyAugusta$1.4M
- John RheeAtlanta$1.1M
- Tapan DaftariAustell$759K
- Paul JeffordsAtlanta$651K
- Raphael RoybalSavannah$400K
- Hewatt SimsDouglas$376K
- James MalcolmMarietta$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.